©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 111419
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111419
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111419
Table 3 Phase-specific interventions in pediatric leukemia
| Phase | Key intervention | Agent | Clinical note | Ref. |
| Pre-diagnosis | Maternal probiotics | L. rhamnosus GG + Bifidobacterium infantis | 38% reduced offspring ALL risk | Kameri et al[10], 2024 |
| Pre-diagnosis | Breastfeeding | Exclusive > 6 months | 27% reduced ALL risk | Kameri et al[10], 2024 |
| Chemo | Probiotics | L. rhamnosus GG | Reduced gastrointestinal toxicity/infections | Martyniak et al[20], 2023 |
| Chemo | Prebiotics | Inulin + butyrate | Increased tolerance | Martyniak et al[20], 2023 |
| Chemo | Antibiotic stewardship | Reduced fluoroquinolone use | Preserves commensals | Dunn et al[11], 2022 |
| HSCT | Enteral nutrition | Enteral nutrition vs parenteral nutrition | Maintains gut structure | Muratore et al[19], 2022 |
| HSCT | Lactose avoidance | Lactose-free diet | Reduced Enterococcus dominance | Muratore et al[19], 2022 |
| Recovery | Microbiome restoration | Fecal microbiome transplantation/targeted probiotics | Reduced late effects 29% | Todor and Ichim[8], 2025 |
- Citation: Roganovic J, Radosevic M, Dordevic A. Role of the gut microbiome in the development and prognosis of pediatric leukemia. World J Clin Oncol 2025; 16(11): 111419
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/111419.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.111419